- Home
- CGEN vs BSET Comparison
CGEN vs BSET Comparison
Compare CGEN & BSET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEN
- BSET
- Stock Information
- Founded
- CGEN 1993
- BSET 1902
- Country
- CGEN Israel
- BSET United States
- Employees
- CGEN 74
- BSET N/A
- Industry
- CGEN Biotechnology: Biological Products (No Diagnostic Substances)
- BSET Home Furnishings
- Sector
- CGEN Health Care
- BSET Consumer Discretionary
- Exchange
- CGEN Nasdaq
- BSET Nasdaq
- Market Cap
- CGEN 125.3M
- BSET 135.3M
- IPO Year
- CGEN 2000
- BSET 1987
- Fundamental
- Price
- CGEN $1.38
- BSET $16.36
- Analyst Decision
- CGEN
- BSET
- Analyst Count
- CGEN 0
- BSET 0
- Target Price
- CGEN N/A
- BSET N/A
- AVG Volume (30 Days)
- CGEN 238.3K
- BSET 20.7K
- Earning Date
- CGEN 11-11-2025
- BSET 10-08-2025
- Dividend Yield
- CGEN N/A
- BSET 4.89%
- EPS Growth
- CGEN N/A
- BSET N/A
- EPS
- CGEN N/A
- BSET 0.28
- Revenue
- CGEN $22,144,000.00
- BSET $326,469,000.00
- Revenue This Year
- CGEN N/A
- BSET $3.18
- Revenue Next Year
- CGEN $159.40
- BSET $3.84
- P/E Ratio
- CGEN N/A
- BSET $58.26
- Revenue Growth
- CGEN N/A
- BSET N/A
- 52 Week Low
- CGEN $1.13
- BSET $13.38
- 52 Week High
- CGEN $2.66
- BSET $19.75
- Technical
- Relative Strength Index (RSI)
- CGEN 41.92
- BSET 47.22
- Support Level
- CGEN $1.39
- BSET $16.27
- Resistance Level
- CGEN $1.47
- BSET $17.12
- Average True Range (ATR)
- CGEN 0.06
- BSET 0.51
- MACD
- CGEN -0.00
- BSET -0.01
- Stochastic Oscillator
- CGEN 33.33
- BSET 17.24
About CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
About BSET Bassett Furniture Industries Incorporated
Bassett Furniture Industries Inc is a manufacturer, marketer, and retailer of home furnishings products in the United States. It operates through the following segments: The Wholesale segment focuses on the design, manufacture, sourcing, sale, and distribution of furniture products, the Retail segment which consists of company-owned stores, and the Corporate and others segment. Majority of revenue is from Wholesale sales of furniture and accessories.